Glenfield Mallareddy Brainheart Hospitals Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 17-12-2024
- Paid Up Capital ₹ 0.40 M
as on 17-12-2024
- Company Age 3 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.70 Cr
as on 17-12-2024
- Revenue %
(FY 2023)
- Profit -239.09%
(FY 2023)
- Ebitda -208.45%
(FY 2023)
- Net Worth -582.97%
(FY 2023)
- Total Assets 451.36%
(FY 2023)
About Glenfield Mallareddy Brainheart Hospitals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.40 M.
The company currently has active open charges totaling ₹7.70 Cr.
Bhadra Chamakura, Syed Kirmani, and Younus Mohammed serve as directors at the Company.
- CIN/LLPIN
U85300TG2021PTC153787
- Company No.
153787
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Aug 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Glenfield Mallareddy Brainheart Hospitals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhadra Chamakura  | Director | 04-Aug-2021 | Current |
| Syed Kirmani | Director | 04-Aug-2021 | Current |
| Younus Mohammed | Director | 04-Aug-2021 | Current |
Financial Performance of Glenfield Mallareddy Brainheart Hospitals.
Glenfield Mallareddy Brainheart Hospitals Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 239.09% decrease in profit. The company's net worth observed a substantial decline by a decrease of 582.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Glenfield Mallareddy Brainheart Hospitals?
In 2023, Glenfield Mallareddy Brainheart Hospitals had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Mallareddy Foundation For Research & InnovationsActive 4 years 11 months
Bhadra Chamakura is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 08 Aug 2023 | ₹7.70 Cr | Open |
How Many Employees Work at Glenfield Mallareddy Brainheart Hospitals?
Glenfield Mallareddy Brainheart Hospitals has a workforce of 0 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Glenfield Mallareddy Brainheart Hospitals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Glenfield Mallareddy Brainheart Hospitals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
